Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
School of Health and Related Research, University of Sheffield, Sheffield, UK.
J Clin Endocrinol Metab. 2020 Apr 1;105(4):e1171-86. doi: 10.1210/clinem/dgaa084.
Normocalcemic hyperparathyroidism (NPHPT) is characterized by persistently normal calcium levels and elevated parathyroid hormone (PTH) values, after excluding other causes of secondary hyperparathyroidism. The prevalence of the disease varies greatly and the data on the natural history of this disease are sparse and inconclusive.
The objectives of this study are to describe the prevalence of NPHPT and its natural history in a referral population and to compare the variability of serum calcium with a group of patients with primary hyperparathyroidism (PHPT).
A retrospective study was conducted over 5 years.
The setting for this study was a metabolic bone referral center.
A total of 6280 patients were referred for a bone mineral density measurement (BMD).
The prevalence and natural history of NPHPT and variability of calcium were the main outcome measures.
We identified NPHPT patients using data from the day of the BMD measurement. We excluded patients with low estimated glomerular filtration rate (eGFR) or vitamin D, or with no measurements available. Based on the evaluation of their medical files, we identified 11 patients with NPHPT (prevalence 0.18%). Only 4 patients had consistent normocalcemia throughout their follow-up, with only 2 also having consistently high PTH. None had consistently normal eGFR or vitamin D.Intermittent hypercalcemia was present in 7 of the 11 NPHPT patients. The mean adjusted calcium was found to be significantly lower in the NPHPT group compared with the PHPT group but higher than the control group. PTH was similar for NPHPT and PHPT. These 2 groups had similar variability in serum calcium.
NPHPT patients often have episodes of hypercalcemia. We believe that NPHPT is a mild form of PHPT.
血钙正常的甲状旁腺功能亢进症(NPHPT)的特征是在排除其他继发性甲状旁腺功能亢进症的原因后,持续保持正常的钙水平和升高的甲状旁腺激素(PTH)值。该疾病的患病率差异很大,而且关于该疾病自然史的数据稀少且不确定。
本研究旨在描述一个转诊人群中 NPHPT 的患病率及其自然史,并比较血清钙的变异性与一组原发性甲状旁腺功能亢进症(PHPT)患者。
回顾性研究,历时 5 年。
本研究的地点是一个代谢性骨病转诊中心。
共有 6280 名患者因骨密度测量(BMD)而被转介。
NPHPT 的患病率和自然史以及钙的变异性是主要观察指标。
我们使用 BMD 测量当天的数据确定了 NPHPT 患者。我们排除了肾小球滤过率(eGFR)或维生素 D 低或无测量值的患者。根据对其病历的评估,我们确定了 11 名 NPHPT 患者(患病率为 0.18%)。只有 4 名患者在整个随访过程中血钙始终正常,只有 2 名患者 PTH 也始终升高。没有患者的 eGFR 或维生素 D 始终正常。11 名 NPHPT 患者中有 7 名存在间歇性高钙血症。与 PHPT 组相比,NPHPT 组的平均校正钙明显较低,但高于对照组。NPHPT 和 PHPT 组的 PTH 相似。这两组的血清钙变异性相似。
NPHPT 患者常有高钙血症发作。我们认为 NPHPT 是 PHPT 的一种轻度形式。